🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Carcinoma Stage II

A Study of JMT203 in Patients With Cancer Cachexia NCT06868849Phase 1, Phase 21 site📍 Zhejiang Shanghai JMT-Bio Inc. · Tests: JMT203 Injection, JMT203 Injection CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients NCT06730009Phase 1, Phase 21 site📍 Tainan Medigen Biotechnology Corporation · Tests: SLOG + Allogeneic NK cell, SLOG chemotherapy TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion NCT07594626Phase 1, Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Pemetrexed, PRMT5 Inhibitor BMS-986504 Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer NCT06958328Phase 3333 sites📍 Gilbert📍 Gilbert📍 Peoria NRG Oncology · Tests: Biopsy Procedure, Biospecimen Collection, Capecitabine, Computed Tomography, Dose-escalated Radiation Therapy Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients NCT06893783Phase 24 sites📍 Seoul📍 Seoul📍 Seoul Inkeun Park · Tests: Tarlatamab Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" NCT01365169NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Exercise Intervention, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients NCT06770452Phase 22 sites📍 Hangzhou📍 Hangzhou Zhejiang University · Tests: HRS-4642, Nimotuzumab, gemcitabine + nab-paclitaxel OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma NCT07089940EARLY Phase 11 site📍 Portland OHSU Knight Cancer Institute · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Myc Inhibitor OMO-103 Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma NCT07214298Phase 1, Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Fluorouracil, Irinotecan Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors NCT03755739Phase 2, Phase 31 site📍 Guanzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer NCT01174121Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Pembrolizumab (Keytruda), Fludarabine, Cyclophosphamide, Aldesleukin, Young TIL A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors NCT05053971Phase 1, Phase 23 sites📍 New Haven📍 Gainesville📍 Oklahoma City National Cancer Institute (NCI) · Tests: BET Bromodomain Inhibitor ZEN-3694, Computed Tomography, Core Biopsy, Entinostat Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT07435038Phase 1, Phase 27 sites📍 Blacktown📍 Randwick📍 Sydney Betta Pharmaceuticals Co., Ltd. · Tests: BPI-572270 Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) NCT05191940NA1 site📍 Wiener Neustadt EBG MedAustron GmbH · Tests: Particle-therapy using protons or carbon ions, Blood sampling, Magnetic resonance imaging, Computertomography, 18-F-Flu… Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas NCT02598349Phase 24 sites📍 Little Rock📍 Jacksonville📍 Warrenville Proton Collaborative Group · Tests: Proton Radiation, Capecitabine, Surgical resection mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients NCT04084496Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Folfirinox Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors NCT05040360Phase 2448 sites📍 Anchorage📍 Anchorage📍 Anchorage SWOG Cancer Research Network · Tests: Capecitabine, Temozolomide Pancreatic Cancer Detection Consortium NCT06388967n/a13 sites📍 Phoenix📍 Scottsdale📍 Monrovia City of Hope Medical Center · Tests: PANcreatic cancer Exosome Early detectiON (PANXEON) A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy NCT07651358NA1 site📍 Portland OHSU Knight Cancer Institute · Tests: Physical Activity and Nutritional Recommendations and Support Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer NCT06423326Phase 22 sites📍 Washington D.C.📍 Atlanta Georgetown University · Tests: Biopsy, Biospecimen Collection, Cisplatin, Computed Tomography, Gemcitabine Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer NCT05841420Phase 21 site📍 Aalborg Morten Ladekarl · Tests: Gemcitabine, Nab paclitaxel A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer NCT06380816Phase 1, Phase 24 sites📍 London📍 Manchester📍 Newcastle upon Tyne Cancer Research UK · Tests: UCB4594 A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations NCT06906562Phase 2109 sites📍 Birmingham📍 Mobile📍 Montgomery Sameek Roychowdhury · Tests: Pemigatinib, Computed Tomography (CT), Magnetic Resonance Imaging, Optical Coherence Tomography, Bone Scan Targeted Pathway Inhibition in Patients With Pancreatic Cancer NCT04005690EARLY Phase 11 site📍 Portland OHSU Knight Cancer Institute · Tests: Cobimetinib, Olaparib, Onvansertib, Azenosertib, Saruparib APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation NCT04858334Phase 2456 sites📍 Anchorage📍 Anchorage📍 Anchorage National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib, Placebo Administration Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels NCT07282912Phase 21 site📍 New Haven Yale University · Tests: Sequential cytoreductive intervention, Signatera Genome ultra-sensitive ctDNA blood test Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders NCT00830557n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: medical chart review, survey administration, biospecimen collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy